JP Morgan Healthcare Conference Review
JP Morgan Healthcare Conference Review
$3,000.00
The 2018 JP Morgan Healthcare Conference held in San Francisco over 8–11 January 2018 was light on big news and deals, but PharmaVitae picked up on key themes for some of the presenting companies in our coverage universe, which are all experiencing and/or pursuing a change of scene and pace in dealmaking activity.
Author: PharmaVitae
Publisher: Datamonitor Healthcare
- Description
- Contents
Overview
The 2018 JP Morgan Healthcare Conference held in San Francisco over 8–11 January 2018 was light on big news and deals, but PharmaVitae picked up on key themes for some of the presenting companies in our coverage universe, which are all experiencing and/or pursuing a change of scene and pace in dealmaking activity.
- Celgene
- Vertex
- Regeneron
- Alexion
- Sanofi
TABLE OF CONTENTS
4 COMPANY REVIEWS
4 Celgene on the mark
4 Future-oriented Vertex powering ahead
5 Regeneron refreshes its pipeline
6 Alexion getting into shape
6 Sanofi facing the raw end of a renewed deal with Alnylam
© Informa UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Xofigo 
Sign up to the